 | • レポートコード：QYR9N7347 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、誘導多能性幹細胞のグローバル市場について調査・分析したレポートで、種類別（肝細胞、線維芽細胞、ケラチノサイト、羊膜細胞、その他）、用途別（学術研究、創薬と創薬、毒性スクリーニング、再生医療）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・誘導多能性幹細胞の世界市場規模 ・主要企業別市場シェア ・誘導多能性幹細胞の世界市場規模：種類別（肝細胞、線維芽細胞、ケラチノサイト、羊膜細胞、その他） ・誘導多能性幹細胞の世界市場規模：用途別（学術研究、創薬と創薬、毒性スクリーニング、再生医療） ・誘導多能性幹細胞のアメリカ市場規模（種類別、用途別） ・誘導多能性幹細胞のヨーロッパ市場規模（種類別、用途別） ・誘導多能性幹細胞の中国市場規模（種類別、用途別） ・誘導多能性幹細胞の日本市場規模（種類別、用途別） ・誘導多能性幹細胞の東南アジア市場規模（種類別、用途別） ・誘導多能性幹細胞のインド市場規模（種類別、用途別） ・誘導多能性幹細胞の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・誘導多能性幹細胞の世界市場予測（2019年-2025年） ・誘導多能性幹細胞の地域別市場予測（2019年-2025年） ... |
Pluripotent stem cells are embryonic stem cells that have the potential to form all adult cell types and help in repairing of damaged tissues in the human body. An induced pluripotent stem cells, or iPSCs, are taken from any tissue (usually skin or blood) from a child or an adult and is genetically modified to behave like pluripotent stem cells or embryonic stem cells.iPSCs market is in emerging state mainly due to its ability to make any cell or tissue the body might need to encounter wide range of diseases like diabetes, spinal cord injury, leukaemia or heart disease, these cells can potentially be customized to provide a perfect genetic match for any patient.
In 2018, the global Induced Pluripotent Stem Cells market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Induced Pluripotent Stem Cells status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Induced Pluripotent Stem Cells development in United States, Europe and China.
The key players covered in this study
Fujifilm Holding Corporation
Astellas Pharma
Fate Therapeutics
Bristol-Myers Squibb Company
ViaCyte
Celgene Corporation
Aastrom Biosciences
Acelity Holdings
StemCells
Japan Tissue Engineering
Organogenesis
Market segment by Type, the product can be split into
Hepatocytes
Fibroblasts
Keratinocytes
Amniotic Cells
Others
Market segment by Application, split into
Academic Research
Drug Development And Discovery
Toxicity Screening
Regenerative Medicine
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Induced Pluripotent Stem Cells status, future forecast, growth opportunity, key market and key players.
To present the Induced Pluripotent Stem Cells development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Induced Pluripotent Stem Cells are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Induced Pluripotent Stem Cells Market Size Growth Rate by Type (2014-2025)
1.4.2 Hepatocytes
1.4.3 Fibroblasts
1.4.4 Keratinocytes
1.4.5 Amniotic Cells
1.4.6 Others
1.5 Market by Application
1.5.1 Global Induced Pluripotent Stem Cells Market Share by Application (2014-2025)
1.5.2 Academic Research
1.5.3 Drug Development And Discovery
1.5.4 Toxicity Screening
1.5.5 Regenerative Medicine
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Induced Pluripotent Stem Cells Market Size
2.2 Induced Pluripotent Stem Cells Growth Trends by Regions
2.2.1 Induced Pluripotent Stem Cells Market Size by Regions (2014-2025)
2.2.2 Induced Pluripotent Stem Cells Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Induced Pluripotent Stem Cells Market Size by Manufacturers
3.1.1 Global Induced Pluripotent Stem Cells Revenue by Manufacturers (2014-2019)
3.1.2 Global Induced Pluripotent Stem Cells Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Induced Pluripotent Stem Cells Market Concentration Ratio (CR5 and HHI)
3.2 Induced Pluripotent Stem Cells Key Players Head office and Area Served
3.3 Key Players Induced Pluripotent Stem Cells Product/Solution/Service
3.4 Date of Enter into Induced Pluripotent Stem Cells Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Induced Pluripotent Stem Cells Market Size by Type (2014-2019)
4.2 Global Induced Pluripotent Stem Cells Market Size by Application (2014-2019)
5 United States
5.1 United States Induced Pluripotent Stem Cells Market Size (2014-2019)
5.2 Induced Pluripotent Stem Cells Key Players in United States
5.3 United States Induced Pluripotent Stem Cells Market Size by Type
5.4 United States Induced Pluripotent Stem Cells Market Size by Application
6 Europe
6.1 Europe Induced Pluripotent Stem Cells Market Size (2014-2019)
6.2 Induced Pluripotent Stem Cells Key Players in Europe
6.3 Europe Induced Pluripotent Stem Cells Market Size by Type
6.4 Europe Induced Pluripotent Stem Cells Market Size by Application
7 China
7.1 China Induced Pluripotent Stem Cells Market Size (2014-2019)
7.2 Induced Pluripotent Stem Cells Key Players in China
7.3 China Induced Pluripotent Stem Cells Market Size by Type
7.4 China Induced Pluripotent Stem Cells Market Size by Application
8 Japan
8.1 Japan Induced Pluripotent Stem Cells Market Size (2014-2019)
8.2 Induced Pluripotent Stem Cells Key Players in Japan
8.3 Japan Induced Pluripotent Stem Cells Market Size by Type
8.4 Japan Induced Pluripotent Stem Cells Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Induced Pluripotent Stem Cells Market Size (2014-2019)
9.2 Induced Pluripotent Stem Cells Key Players in Southeast Asia
9.3 Southeast Asia Induced Pluripotent Stem Cells Market Size by Type
9.4 Southeast Asia Induced Pluripotent Stem Cells Market Size by Application
10 India
10.1 India Induced Pluripotent Stem Cells Market Size (2014-2019)
10.2 Induced Pluripotent Stem Cells Key Players in India
10.3 India Induced Pluripotent Stem Cells Market Size by Type
10.4 India Induced Pluripotent Stem Cells Market Size by Application
11 Central & South America
11.1 Central & South America Induced Pluripotent Stem Cells Market Size (2014-2019)
11.2 Induced Pluripotent Stem Cells Key Players in Central & South America
11.3 Central & South America Induced Pluripotent Stem Cells Market Size by Type
11.4 Central & South America Induced Pluripotent Stem Cells Market Size by Application
12 International Players Profiles
12.1 Fujifilm Holding Corporation
12.1.1 Fujifilm Holding Corporation Company Details
12.1.2 Company Description and Business Overview
12.1.3 Induced Pluripotent Stem Cells Introduction
12.1.4 Fujifilm Holding Corporation Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
12.1.5 Fujifilm Holding Corporation Recent Development
12.2 Astellas Pharma
12.2.1 Astellas Pharma Company Details
12.2.2 Company Description and Business Overview
12.2.3 Induced Pluripotent Stem Cells Introduction
12.2.4 Astellas Pharma Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
12.2.5 Astellas Pharma Recent Development
12.3 Fate Therapeutics
12.3.1 Fate Therapeutics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Induced Pluripotent Stem Cells Introduction
12.3.4 Fate Therapeutics Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
12.3.5 Fate Therapeutics Recent Development
12.4 Bristol-Myers Squibb Company
12.4.1 Bristol-Myers Squibb Company Company Details
12.4.2 Company Description and Business Overview
12.4.3 Induced Pluripotent Stem Cells Introduction
12.4.4 Bristol-Myers Squibb Company Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
12.4.5 Bristol-Myers Squibb Company Recent Development
12.5 ViaCyte
12.5.1 ViaCyte Company Details
12.5.2 Company Description and Business Overview
12.5.3 Induced Pluripotent Stem Cells Introduction
12.5.4 ViaCyte Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
12.5.5 ViaCyte Recent Development
12.6 Celgene Corporation
12.6.1 Celgene Corporation Company Details
12.6.2 Company Description and Business Overview
12.6.3 Induced Pluripotent Stem Cells Introduction
12.6.4 Celgene Corporation Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
12.6.5 Celgene Corporation Recent Development
12.7 Aastrom Biosciences
12.7.1 Aastrom Biosciences Company Details
12.7.2 Company Description and Business Overview
12.7.3 Induced Pluripotent Stem Cells Introduction
12.7.4 Aastrom Biosciences Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
12.7.5 Aastrom Biosciences Recent Development
12.8 Acelity Holdings
12.8.1 Acelity Holdings Company Details
12.8.2 Company Description and Business Overview
12.8.3 Induced Pluripotent Stem Cells Introduction
12.8.4 Acelity Holdings Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
12.8.5 Acelity Holdings Recent Development
12.9 StemCells
12.9.1 StemCells Company Details
12.9.2 Company Description and Business Overview
12.9.3 Induced Pluripotent Stem Cells Introduction
12.9.4 StemCells Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
12.9.5 StemCells Recent Development
12.10 Japan Tissue Engineering
12.10.1 Japan Tissue Engineering Company Details
12.10.2 Company Description and Business Overview
12.10.3 Induced Pluripotent Stem Cells Introduction
12.10.4 Japan Tissue Engineering Revenue in Induced Pluripotent Stem Cells Business (2014-2019)
12.10.5 Japan Tissue Engineering Recent Development
12.11 Organogenesis
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Induced Pluripotent Stem Cells Key Market Segments
Table Key Players Induced Pluripotent Stem Cells Covered
Table Global Induced Pluripotent Stem Cells Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Induced Pluripotent Stem Cells Market Size Market Share by Type 2014-2025
Figure Hepatocytes Figures
Table Key Players of Hepatocytes
Figure Fibroblasts Figures
Table Key Players of Fibroblasts
Figure Keratinocytes Figures
Table Key Players of Keratinocytes
Figure Amniotic Cells Figures
Table Key Players of Amniotic Cells
Figure Others Figures
Table Key Players of Others
Table Global Induced Pluripotent Stem Cells Market Size Growth by Application 2014-2025 (Million US$)
Figure Academic Research Case Studies
Figure Drug Development And Discovery Case Studies
Figure Toxicity Screening Case Studies
Figure Regenerative Medicine Case Studies
Figure Induced Pluripotent Stem Cells Report Years Considered
Table Global Induced Pluripotent Stem Cells Market Size 2014-2025 (Million US$)
Figure Global Induced Pluripotent Stem Cells Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Induced Pluripotent Stem Cells Market Size by Regions 2014-2025 (Million US$)
Table Global Induced Pluripotent Stem Cells Market Size by Regions 2014-2019 (Million US$)
Table Global Induced Pluripotent Stem Cells Market Share by Regions 2014-2019
Figure Global Induced Pluripotent Stem Cells Market Share by Regions 2014-2019
Figure Global Induced Pluripotent Stem Cells Market Share by Regions 2019
Table Market Top Trends
Table Global Induced Pluripotent Stem Cells Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Induced Pluripotent Stem Cells Market Share by Manufacturers (2014-2019)
Figure Global Induced Pluripotent Stem Cells Market Share by Manufacturers in 2018
Table Global Induced Pluripotent Stem Cells Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Induced Pluripotent Stem Cells Product/Solution/Service
Table Date of Enter into Induced Pluripotent Stem Cells Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Induced Pluripotent Stem Cells Market Size by Type (2014-2019) (Million US$)
Table Global Induced Pluripotent Stem Cells Market Size Share by Type (2014-2019)
Figure Global Induced Pluripotent Stem Cells Market Size Market Share by Type (2014-2019)
Table Global Induced Pluripotent Stem Cells Market Size by Application (2014-2019) (Million US$)
Table Global Induced Pluripotent Stem Cells Market Size Share by Application (2014-2019)
Figure Global Induced Pluripotent Stem Cells Market Size Market Share by Application (2014-2019)
Figure Global Induced Pluripotent Stem Cells Revenue Market Share by Application in 2018
Figure United States Induced Pluripotent Stem Cells Market Size 2014-2019 (Million US$)
Table United States Key Players Induced Pluripotent Stem Cells Revenue (2018-2019) (Million US$)
Table United States Key Players Induced Pluripotent Stem Cells Market Share (2018-2019)
Table United States Induced Pluripotent Stem Cells Market Size by Type (2014-2019) (Million US$)
Table United States Induced Pluripotent Stem Cells Market Share by Type (2014-2019)
Table United States Induced Pluripotent Stem Cells Market Size by Application (2014-2019) (Million US$)
Table United States Induced Pluripotent Stem Cells Market Share by Application (2014-2019)
Figure Europe Induced Pluripotent Stem Cells Market Size 2014-2019 (Million US$)
Table Europe Key Players Induced Pluripotent Stem Cells Revenue (2018-2019) (Million US$)
Table Europe Key Players Induced Pluripotent Stem Cells Market Share (2018-2019)
Table Europe Induced Pluripotent Stem Cells Market Size by Type (2014-2019) (Million US$)
Table Europe Induced Pluripotent Stem Cells Market Share by Type (2014-2019)
Table Europe Induced Pluripotent Stem Cells Market Size by Application (2014-2019) (Million US$)
Table Europe Induced Pluripotent Stem Cells Market Share by Application (2014-2019)
Figure China Induced Pluripotent Stem Cells Market Size 2014-2019 (Million US$)
Table China Key Players Induced Pluripotent Stem Cells Revenue (2018-2019) (Million US$)
Table China Key Players Induced Pluripotent Stem Cells Market Share (2018-2019)
Table China Induced Pluripotent Stem Cells Market Size by Type (2014-20189) (Million US$)
Table China Induced Pluripotent Stem Cells Market Share by Type (2014-2019)
Table China Induced Pluripotent Stem Cells Market Size by Application (2014-2019) (Million US$)
Table China Induced Pluripotent Stem Cells Market Share by Application (2014-2019)
Figure Japan Induced Pluripotent Stem Cells Market Size 2014-2019 (Million US$)
Table Japan Key Players Induced Pluripotent Stem Cells Revenue (2018-2019) (Million US$)
Table Japan Key Players Induced Pluripotent Stem Cells Market Share (2018-2019)
Table Japan Induced Pluripotent Stem Cells Market Size by Type (2014-2019) (Million US$)
Table Japan Induced Pluripotent Stem Cells Market Share by Type (2014-2019)
Table Japan Induced Pluripotent Stem Cells Market Size by Application (2014-2019) (Million US$)
Table Japan Induced Pluripotent Stem Cells Market Share by Application (2014-2019)
Figure Southeast Asia Induced Pluripotent Stem Cells Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Induced Pluripotent Stem Cells Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Induced Pluripotent Stem Cells Market Share (2018-2019)
Table Southeast Asia Induced Pluripotent Stem Cells Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Induced Pluripotent Stem Cells Market Share by Type (2014-2019)
Table Southeast Asia Induced Pluripotent Stem Cells Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Induced Pluripotent Stem Cells Market Share by Application (2014-2019)
Figure India Induced Pluripotent Stem Cells Market Size 2014-2019 (Million US$)
Table India Key Players Induced Pluripotent Stem Cells Revenue (2018-2019) (Million US$)
Table India Key Players Induced Pluripotent Stem Cells Market Share (2018-2019)
Table India Induced Pluripotent Stem Cells Market Size by Type (2014-2019) (Million US$)
Table India Induced Pluripotent Stem Cells Market Share by Type (2014-2019)
Table India Induced Pluripotent Stem Cells Market Size by Application (2014-2019) (Million US$)
Table India Induced Pluripotent Stem Cells Market Share by Application (2014-2019)
Figure Central & South America Induced Pluripotent Stem Cells Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Induced Pluripotent Stem Cells Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Induced Pluripotent Stem Cells Market Share (2018-2019)
Table Central & South America Induced Pluripotent Stem Cells Market Size by Type (2014-2019) (Million US$)
Table Central & South America Induced Pluripotent Stem Cells Market Share by Type (2014-2019)
Table Central & South America Induced Pluripotent Stem Cells Market Size by Application (2014-2019) (Million US$)
Table Central & South America Induced Pluripotent Stem Cells Market Share by Application (2014-2019)
Table Fujifilm Holding Corporation Company Details
Table Fujifilm Holding Corporation Revenue in Induced Pluripotent Stem Cells Business (2014-2019) (Million US$)
Figure Fujifilm Holding Corporation Revenue Growth Rate in Induced Pluripotent Stem Cells Business (2014-2019)
Table Fujifilm Holding Corporation Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Revenue in Induced Pluripotent Stem Cells Business (2014-2019)(Million US$)
Figure Astellas Pharma Revenue Growth Rate in Induced Pluripotent Stem Cells Business (2014-2019)
Table Astellas Pharma Recent Development
Table Fate Therapeutics Company Details
Table Fate Therapeutics Revenue in Induced Pluripotent Stem Cells Business (2014-2019)(Million US$)
Figure Fate Therapeutics Revenue Growth Rate in Induced Pluripotent Stem Cells Business (2014-2019)
Table Fate Therapeutics Recent Development
Table Bristol-Myers Squibb Company Company Details
Table Bristol-Myers Squibb Company Revenue in Induced Pluripotent Stem Cells Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Company Revenue Growth Rate in Induced Pluripotent Stem Cells Business (2014-2019)
Table Bristol-Myers Squibb Company Recent Development
Table ViaCyte Company Details
Table ViaCyte Revenue in Induced Pluripotent Stem Cells Business (2014-2019)(Million US$)
Figure ViaCyte Revenue Growth Rate in Induced Pluripotent Stem Cells Business (2014-2019)
Table ViaCyte Recent Development
Table Celgene Corporation Company Details
Table Celgene Corporation Revenue in Induced Pluripotent Stem Cells Business (2014-2019)(Million US$)
Figure Celgene Corporation Revenue Growth Rate in Induced Pluripotent Stem Cells Business (2014-2019)
Table Celgene Corporation Recent Development
Table Aastrom Biosciences Company Details
Table Aastrom Biosciences Revenue in Induced Pluripotent Stem Cells Business (2014-2019)(Million US$)
Figure Aastrom Biosciences Revenue Growth Rate in Induced Pluripotent Stem Cells Business (2014-2019)
Table Aastrom Biosciences Recent Development
Table Acelity Holdings Company Details
Table Acelity Holdings Revenue in Induced Pluripotent Stem Cells Business (2014-2019)(Million US$)
Figure Acelity Holdings Revenue Growth Rate in Induced Pluripotent Stem Cells Business (2014-2019)
Table Acelity Holdings Recent Development
Table StemCells Company Details
Table StemCells Revenue in Induced Pluripotent Stem Cells Business (2014-2019)(Million US$)
Figure StemCells Revenue Growth Rate in Induced Pluripotent Stem Cells Business (2014-2019)
Table StemCells Recent Development
Table Japan Tissue Engineering Company Details
Table Japan Tissue Engineering Revenue in Induced Pluripotent Stem Cells Business (2014-2019)(Million US$)
Figure Japan Tissue Engineering Revenue Growth Rate in Induced Pluripotent Stem Cells Business (2014-2019)
Table Japan Tissue Engineering Recent Development
Table Organogenesis Company Details
Table Global Induced Pluripotent Stem Cells Market Size by Regions (Million US$) 2019-2025
Figure Global Induced Pluripotent Stem Cells Market Size Share by Regions (2019-2025)
Figure Global Induced Pluripotent Stem Cells Market Size Share by Regions in 2025
Figure United States Induced Pluripotent Stem Cells Market Size Forecast (2019-2025)(Million USD)
Figure Europe Induced Pluripotent Stem Cells Market Size Forecast (2019-2025)(Million USD)
Figure China Induced Pluripotent Stem Cells Market Size Forecast (2019-2025)(Million USD)
Figure Japan Induced Pluripotent Stem Cells Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Induced Pluripotent Stem Cells Market Size Forecast (2019-2025)(Million USD)
Figure India Induced Pluripotent Stem Cells Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Induced Pluripotent Stem Cells Market Size Forecast (2019-2025)(Million USD)
Table Global Induced Pluripotent Stem Cells Market Size by Product (2019-2025) (Million US$)
Figure Global Induced Pluripotent Stem Cells Market Size by Product (2019-2025)
Figure Global Induced Pluripotent Stem Cells Market Size by Product in 2025
Table Global Induced Pluripotent Stem Cells Market Size by Application (2019-2025) (Million US$)
Figure Global Induced Pluripotent Stem Cells Market Size by Application (2019-2025)
Figure Global Induced Pluripotent Stem Cells Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の間葉系幹細胞市場：市場規模・現状・予測 Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neuron…- 世界のKセル市場：市場規模・現状・予測 In 2018, the global K Cells market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global K Cells status, future forecast, growth opportunity, key market and key players. The study objectives are t…
- 世界のオピオイド誘発性便秘治療市場：市場規模・現状・予測 There are multiple drugs in the pipeline for opioid induced constipation treatment. Upon approval, these drugs will face little competition in this market which is largely untapped. There have not been many stable choices in the pharmaceutical industry for opioid induced constipation treatment over …
- 世界のヒト胚性幹細胞（hESC）市場：市場規模・現状・予測 Human embryonic stem cell research has emerged as an importantplatform for the understanding and treatment of pediatric diseases. From its inception, however, it has raised ethical concerns based not on the use of stem cells themselves but on objections to the source of the cells—specifically, the d…
- 世界の太陽電池市場2019 The global Solar Cells market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Solar Cells market status and forecast, categorizes the global Solar Cells market size (value & volume) by key players,…